Edwards Lifesciences Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$1,741,000	$1,648,600	$1,569,600	$1,553,100
Gross Profit	1,350,400	1,289,300	1,229,000	1,209,600
EBITDA	519,500	499,900	133,100	387,600
EBIT		459,000	90,400	348,400
Net Income	241,900	380,700	91,200	291,100
Net Change In Cash	1,741,000	1,648,600	1,569,600	1,553,100
Free Cash Flow	585,000	-21,100	353,500	516,200
Cash	2,906,500	2,446,500	2,938,500	2,685,600
Basic Shares	577,600	580,700	581,800	585,700

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$6,067,600	$5,439,500	$6,004,800	$5,382,400
Gross Profit	4,740,700	4,322,000	4,625,000	4,215,200
EBITDA	1,429,500	1,723,100	1,534,100	1,960,400
EBIT	1,272,900	1,567,900	1,534,100	1,793,600
Net Income	1,073,500	4,174,600	1,402,400	1,521,900
Net Change In Cash	6,067,600	5,439,500	6,004,800	5,382,400
Cost of Revenue				-114,000
Free Cash Flow	1,335,000	289,900	629,500	953,400
Cash	2,938,500	3,045,200	1,132,300	769,000
Basic Shares	585,800	599,300	609,400	624,200